Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 88

1.

Genomic Instability Is Induced by Persistent Proliferation of Cells Undergoing Epithelial-to-Mesenchymal Transition.

Comaills V, Kabeche L, Morris R, Buisson R, Yu M, Madden MW, LiCausi JA, Boukhali M, Tajima K, Pan S, Aceto N, Sil S, Zheng Y, Sundaresan T, Yae T, Jordan NV, Miyamoto DT, Ting DT, Ramaswamy S, Haas W, Zou L, Haber DA, Maheswaran S.

Cell Rep. 2016 Dec 6;17(10):2632-2647. doi: 10.1016/j.celrep.2016.11.022.

2.

Transforming growth factor-β 1 enhances the invasiveness of breast cancer cells by inducing a Smad2-dependent epithelial-to-mesenchymal transition.

Lv ZD, Kong B, Li JG, Qu HL, Wang XG, Cao WH, Liu XY, Wang Y, Yang ZC, Xu HM, Wang HB.

Oncol Rep. 2013 Jan;29(1):219-25. doi: 10.3892/or.2012.2111. Epub 2012 Oct 30.

PMID:
23129177
3.

Critical role of miR-10b in transforming growth factor-β1-induced epithelial-mesenchymal transition in breast cancer.

Han X, Yan S, Weijie Z, Feng W, Liuxing W, Mengquan L, Qingxia F.

Cancer Gene Ther. 2014 Feb;21(2):60-7. doi: 10.1038/cgt.2013.82. Epub 2014 Jan 24.

PMID:
24457988
4.

Fibroblast growth factor receptor splice variants are stable markers of oncogenic transforming growth factor β1 signaling in metastatic breast cancers.

Wendt MK, Taylor MA, Schiemann BJ, Sossey-Alaoui K, Schiemann WP.

Breast Cancer Res. 2014 Mar 11;16(2):R24. doi: 10.1186/bcr3623.

5.

Mesenchymal stem cells play a potential role in regulating the establishment and maintenance of epithelial-mesenchymal transition in MCF7 human breast cancer cells by paracrine and induced autocrine TGF-β.

Xu Q, Wang L, Li H, Han Q, Li J, Qu X, Huang S, Zhao RC.

Int J Oncol. 2012 Sep;41(3):959-68. doi: 10.3892/ijo.2012.1541. Epub 2012 Jul 3.

PMID:
22766682
6.

Vasohibin-2 is required for epithelial-mesenchymal transition of ovarian cancer cells by modulating transforming growth factor-β signaling.

Norita R, Suzuki Y, Furutani Y, Takahashi K, Yoshimatsu Y, Podyma-Inoue KA, Watabe T, Sato Y.

Cancer Sci. 2017 Mar;108(3):419-426. doi: 10.1111/cas.13157.

7.

Identification of integrin α3 as a molecular marker of cells undergoing epithelial-mesenchymal transition and of cancer cells with aggressive phenotypes.

Shirakihara T, Kawasaki T, Fukagawa A, Semba K, Sakai R, Miyazono K, Miyazawa K, Saitoh M.

Cancer Sci. 2013 Sep;104(9):1189-97. doi: 10.1111/cas.12220. Epub 2013 Jul 20.

8.

MiR-155-mediated loss of C/EBPβ shifts the TGF-β response from growth inhibition to epithelial-mesenchymal transition, invasion and metastasis in breast cancer.

Johansson J, Berg T, Kurzejamska E, Pang MF, Tabor V, Jansson M, Roswall P, Pietras K, Sund M, Religa P, Fuxe J.

Oncogene. 2013 Dec 12;32(50):5614-24. doi: 10.1038/onc.2013.322. Epub 2013 Aug 19.

9.

TGF-β1-induced EMT promotes targeted migration of breast cancer cells through the lymphatic system by the activation of CCR7/CCL21-mediated chemotaxis.

Pang MF, Georgoudaki AM, Lambut L, Johansson J, Tabor V, Hagikura K, Jin Y, Jansson M, Alexander JS, Nelson CM, Jakobsson L, Betsholtz C, Sund M, Karlsson MC, Fuxe J.

Oncogene. 2016 Feb 11;35(6):748-60. doi: 10.1038/onc.2015.133. Epub 2015 May 11.

10.

Involvement of gelsolin in TGF-beta 1 induced epithelial to mesenchymal transition in breast cancer cells.

Chen ZY, Wang PW, Shieh DB, Chiu KY, Liou YM.

J Biomed Sci. 2015 Oct 20;22:90. doi: 10.1186/s12929-015-0197-0.

11.

C-phycocyanin suppresses transforming growth factor-β1-induced epithelial mesenchymal transition in human epithelial cells.

Pattarayan D, Rajarajan D, Ayyanar S, Palanichamy R, Subbiah R.

Pharmacol Rep. 2017 Jun;69(3):426-431. doi: 10.1016/j.pharep.2016.12.013. Epub 2017 Jan 5.

PMID:
28288400
12.

Klotho inhibits transforming growth factor-beta1 (TGF-beta1) signaling and suppresses renal fibrosis and cancer metastasis in mice.

Doi S, Zou Y, Togao O, Pastor JV, John GB, Wang L, Shiizaki K, Gotschall R, Schiavi S, Yorioka N, Takahashi M, Boothman DA, Kuro-o M.

J Biol Chem. 2011 Mar 11;286(10):8655-65. doi: 10.1074/jbc.M110.174037. Epub 2011 Jan 5.

13.

Evaluation of transforming growth factor-β1 suppress Pokemon/epithelial-mesenchymal transition expression in human bladder cancer cells.

Li W, Kidiyoor A, Hu Y, Guo C, Liu M, Yao X, Zhang Y, Peng B, Zheng J.

Tumour Biol. 2015 Feb;36(2):1155-62. doi: 10.1007/s13277-014-2625-2. Epub 2014 Oct 22.

PMID:
25722217
14.

Nicotinamide phosphoribosyltransferase promotes epithelial-to-mesenchymal transition as a soluble factor independent of its enzymatic activity.

Soncini D, Caffa I, Zoppoli G, Cea M, Cagnetta A, Passalacqua M, Mastracci L, Boero S, Montecucco F, Sociali G, Lasigliè D, Damonte P, Grozio A, Mannino E, Poggi A, D'Agostino VG, Monacelli F, Provenzani A, Odetti P, Ballestrero A, Bruzzone S, Nencioni A.

J Biol Chem. 2014 Dec 5;289(49):34189-204. doi: 10.1074/jbc.M114.594721. Epub 2014 Oct 20.

15.

MIR-99a and MIR-99b modulate TGF-β induced epithelial to mesenchymal plasticity in normal murine mammary gland cells.

Turcatel G, Rubin N, El-Hashash A, Warburton D.

PLoS One. 2012;7(1):e31032. doi: 10.1371/journal.pone.0031032. Epub 2012 Jan 27.

16.

Cancer-associated fibroblasts induce epithelial-mesenchymal transition of breast cancer cells through paracrine TGF-β signalling.

Yu Y, Xiao CH, Tan LD, Wang QS, Li XQ, Feng YM.

Br J Cancer. 2014 Feb 4;110(3):724-32. doi: 10.1038/bjc.2013.768. Epub 2013 Dec 12.

17.

Stereospecific effects of ginsenoside 20-Rg3 inhibits TGF-β1-induced epithelial-mesenchymal transition and suppresses lung cancer migration, invasion and anoikis resistance.

Kim YJ, Choi WI, Jeon BN, Choi KC, Kim K, Kim TJ, Ham J, Jang HJ, Kang KS, Ko H.

Toxicology. 2014 Aug 1;322:23-33. doi: 10.1016/j.tox.2014.04.002. Epub 2014 May 2.

PMID:
24793912
18.

CDK5 is essential for TGF-β1-induced epithelial-mesenchymal transition and breast cancer progression.

Liang Q, Li L, Zhang J, Lei Y, Wang L, Liu DX, Feng J, Hou P, Yao R, Zhang Y, Huang B, Lu J.

Sci Rep. 2013 Oct 14;3:2932. doi: 10.1038/srep02932.

19.

Role of crosstalk between interleukin-6 and transforming growth factor-beta 1 in epithelial-mesenchymal transition and chemoresistance in biliary tract cancer.

Yamada D, Kobayashi S, Wada H, Kawamoto K, Marubashi S, Eguchi H, Ishii H, Nagano H, Doki Y, Mori M.

Eur J Cancer. 2013 May;49(7):1725-40. doi: 10.1016/j.ejca.2012.12.002. Epub 2013 Jan 5.

PMID:
23298711
20.

The mechanism of epithelial-mesenchymal transition induced by TGF-β1 in neuroblastoma cells.

Shao JB, Gao ZM, Huang WY, Lu ZB.

Int J Oncol. 2017 May;50(5):1623-1633. doi: 10.3892/ijo.2017.3954. Epub 2017 Apr 5.

Supplemental Content

Support Center